From GlobeNewswire: 2025-04-24 10:08:00

The pharmaceutical market is growing significantly due to the rising disease burden globally and increased demand for innovative treatments. The market is expected to reach US$2.84 billion by 2031, with a 7.1% CAGR. Companies are investing heavily in R&D to develop effective treatments, with Asia Pacific leading in revenue share.

The global disease burden, including diabetes, obesity, Alzheimer’s, and cancer, is driving growth in the pharmaceutical industry. Companies are investing billions in R&D to meet the demand for medical advancements. AI, digital health, and innovation are creating opportunities. Japan and India are key players in manufacturing, with personalized medicine and gene therapy gaining traction.

The pharmaceutical market is segmented by molecule type, indication, product, type, and distribution channel. Major players include Johnson & Johnson, Pfizer, Merck, and AstraZeneca. Recent headlines include investments in manufacturing, FDA approvals, and license agreements. The market is expected to continue growing with advancements in technology and regulatory changes.



Read more at GlobeNewswire: Pharmaceutical Market Size is projected to reach US$ 2.84